INS and Alzheimer disease: Some authors have even proposed the existence of a “Type 3 diabetes mellitus”, limited to central nervous system (CNS), as a cause for AD, as they were able to produce an AD-like neurodegeneration in a mouse model after intracerebroventricular injection of streptozotocin, inducing a depletion of CSF insulin without any change in peripheral insulin metabolism [15].